- Home
- AMWD vs SYRE Comparison
AMWD vs SYRE Comparison
Compare AMWD & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- SYRE
- Stock Information
- Founded
- AMWD 1980
- SYRE 2013
- Country
- AMWD United States
- SYRE United States
- Employees
- AMWD N/A
- SYRE N/A
- Industry
- AMWD Forest Products
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- AMWD Basic Materials
- SYRE Health Care
- Exchange
- AMWD Nasdaq
- SYRE Nasdaq
- Market Cap
- AMWD 883.1M
- SYRE 841.4M
- IPO Year
- AMWD N/A
- SYRE 2016
- Fundamental
- Price
- AMWD $56.37
- SYRE $15.30
- Analyst Decision
- AMWD Buy
- SYRE Buy
- Analyst Count
- AMWD 4
- SYRE 6
- Target Price
- AMWD $83.33
- SYRE $55.00
- AVG Volume (30 Days)
- AMWD 155.4K
- SYRE 490.0K
- Earning Date
- AMWD 05-29-2025
- SYRE 05-08-2025
- Dividend Yield
- AMWD N/A
- SYRE N/A
- EPS Growth
- AMWD N/A
- SYRE N/A
- EPS
- AMWD 6.50
- SYRE N/A
- Revenue
- AMWD $1,709,585,000.00
- SYRE N/A
- Revenue This Year
- AMWD $2.77
- SYRE N/A
- Revenue Next Year
- AMWD $4.04
- SYRE N/A
- P/E Ratio
- AMWD $8.67
- SYRE N/A
- Revenue Growth
- AMWD N/A
- SYRE N/A
- 52 Week Low
- AMWD $52.20
- SYRE $10.91
- 52 Week High
- AMWD $106.57
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- AMWD 42.73
- SYRE 51.16
- Support Level
- AMWD $55.01
- SYRE $14.87
- Resistance Level
- AMWD $61.29
- SYRE $15.71
- Average True Range (ATR)
- AMWD 1.93
- SYRE 0.72
- MACD
- AMWD -0.33
- SYRE 0.10
- Stochastic Oscillator
- AMWD 17.11
- SYRE 51.57
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes kitchen cabinets and vanities for the remodeling and new home construction markets. The company offers framed stock cabinets in over 400 different cabinet lines and prices from relatively inexpensive to medium-priced styles. Its products are sold on a national basis across the United States to the remodeling and new home construction markets. The products are sold under the brand names American Woodmark, Simply Woodmark, Timberlake, Shenandoah Cabinetry, Shenandoah Value Series, and Waypoint Living Spaces.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.